NCT05733416View on ClinicalTrials.gov

Intensive Cancer Screening After Cryptogenic Stroke

NARecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Occult Cancer
Interventions
DIAGNOSTIC_TEST

FDG PET/CT

F-fluorodeoxyglucose positron emission/computed tomography

DIAGNOSTIC_TEST

Usual Care

Cancer screening according to sex, age and risk as per Canadian Task Force on Preventative Health Care

Trial Locations (1)

K1Y 4E9

RECRUITING

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
collaborator

Brain Canada

OTHER

collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Canadian Stroke Consortium (CSC)

OTHER

lead

Ottawa Hospital Research Institute

OTHER